院前生命体征对院外心脏骤停神经功能结局的影响:法国全国心脏骤停登记研究结果
该研究基于法国全国院外心脏骤停登记研究,纳入所有成年院外心脏骤停患者,评估院前阶段由移动医疗团队记录的生命体征(外周血氧饱和度SpO2、呼气末二氧化碳ETCO2、收缩压SBP)与第30天神经功能结局(CPC 1–2为良好,CPC 3–5或死亡为不良)的关系。单因素分析显示,与参考范围94–98%相比,SpO2<94%与更差结局相关(RR=1.108,95%CI 1.069–1.147);SpO2 99–100%未见有害(RR=0.9851,95%CI 0.956–1.015)。ETCO2偏离30–40 mmHg参考范围与更差结局相关(<20 mmHg RR=1.191,95%CI 1.143–1.229;20–29 mmHg RR=1.092,95%CI 1.061–1.123;41–50 mmHg RR=1.075,95%CI 1.039–1.110;>50 mmHg RR=1.136,95%CI 1.085–1.179)。与参考范围100–130 mmHg相比,SBP过高或过低均与更差结局相关(<80 mmHg RR=1.203,95%CI 1.158–1.243;80–99 mmHg RR=1.069,95%CI 1.033–1.105;131–160 mmHg RR=1.076,95%CI 1.043–1.110;>160 mmHg RR=1.168,95%CI 1.126
要点
- 院外心脏骤停复苏后昏迷患者,院前SpO2<94%与更差30天神经功能结局相关(RR=1.108,95%CI 1.069–1.147),SpO2 99–100%未见有害。
- 院前ETCO2偏离30–40 mmHg与更差结局相关:<20 mmHg RR=1.191,20–29 mmHg RR=1.092,41–50 mmHg RR=1.075,>50 mmHg RR=1.136。
- 院前收缩压偏离100–130 mmHg与更差结局相关:<80 mmHg RR=1.203,80–99 mmHg RR=1.069,131–160 mmHg RR=1.076,>160 mmHg RR=1.168。
- 多因素分析结果与单因素分析相似,提示院前生命体征对30天神经功能结局可能有实际影响。
- 作者结论认为,SpO2≥94%、ETCO2 30–40 mmHg、SBP 100–130 mmHg与更好预后相关。
适用人群与场景
- 法国全国院外心脏骤停登记研究中所有成年院外心脏骤停患者,且实现自主循环恢复后处于昏迷状态。
诊断标准与关键阈值
- 神经功能结局按第30天脑功能分级(CPC)判定:CPC 1–2为良好,CPC 3–5或死亡为不良。
- 院前生命体征参考范围:SpO2 94–98%,ETCO2 30–40 mmHg,SBP 100–130 mmHg。
研究设计与关键结果
- 研究类型为基于法国全国院外心脏骤停登记研究的分析,纳入所有成年院外心脏骤停患者,评估院前移动医疗团队记录的生命体征与第30天神经功能结局的关系。
- 与SpO2参考范围94–98%相比,SpO2<94%与更差结局相关(RR=1.108,95%CI 1.069–1.147);SpO2 99–100%未见有害(RR=0.9851,95%CI 0.956–1.015)。
- 与ETCO2参考范围30–40 mmHg相比,<20 mmHg(RR=1.191,95%CI 1.143–1.229)、20–29 mmHg(RR=1.092,95%CI 1.061–1.123)、41–50 mmHg(RR=1.075,95%CI 1.039–1.110)、>50 mmHg(RR=1.136,95%CI 1.085–1.179)均与更差结局相关。
- 与SBP参考范围100–130 mmHg相比,<80 mmHg(RR=1.203,95%CI 1.158–1.243)、80–99 mmHg(RR=1.069,95%CI 1.033–1.105)、131–160 mmHg(RR=1.076,95%CI 1.043–1.110)、>160 mmHg(RR=1.168,95%CI 1.126–1.208)均与更差结局相关。
- 多因素分析结果与单因素分析相似。
证据类型、等级与局限
- 证据类型:基于法国全国院外心脏骤停登记研究的分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,院外心脏骤停复苏后昏迷患者,院前SpO2≥94%、ETCO2 30–40 mmHg、SBP 100–130 mmHg与更好预后相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: The targets for vital parameters following return of spontaneous circulation (ROSC) from an out-of-hospital cardiac arrest (OHCA) are based on studies carried out predominantly in intensive care units. Therefore, we studied the pre-hospital phase.
METHOD: We included all adult OHCA from the French OHCA Registry. Vital parameters [peripheral oxygen saturation level (SpO2), end-tidal carbon dioxide (ETCO2) and systolic blood pressure (SBP)] documented during the pre-hospital phase by mobile medical team, were evaluated with regard to the neurological outcome on day 30 (classified as good for Cerebral Performance Category (CPC) 1 - 2, and poor for CPC 3 - 5 or death).
RESULTS: When compared with a reference range of 94-98%, SpO2 values less than 94% were associated with a worse outcome on univariate analysis [relative risk (RR) = 1.108(1.069 - 1.147)]. An SpO2 of 99 - 100% did not appear to be harmful [RR = 0.9851(0.956-1.015)]. ETCO2 values that deviated from the reference of 30 - 40 mmHg were associated with a worse outcome on univariate analysis [<20, RR = 1.191(1.143 - 1.229); 20 - 29, RR = 1.092(1.061 - 1.123); 41 - 50, RR = 1.075(1.039 - 1.110); >50, RR = 1.136(1.085 - 1.179)]. When compared with a reference range of 100 - 130, higher or lower values of SBP were associated with a worse outcome on univariate analysis [<80, RR = 1.203(1.158 - 1.243); 80 - 99, RR = 1.069(1.033 - 1.105); 131 - 160, RR = 1.076(1.043 - 1.110); >160, RR = 1.168(1.126 - 1.208)]. The multivariate analysis yielded similar results.
CONCLUSION: In comatose patients who have achieved ROSC after OHCA, vital parameters in the pre-hospital phase appear to have a real impact on the 30-day neurological outcome. We found that an SpO2 ≥ 94%, an ETCO2 of 30 - 40 mmHg, and an SBP of 100 - 130 mmHg were associated with a better prognosis.
参考来源
- Javaudin F, Desce N, Le Bastard Q, et al. Impact of pre-hospital vital parameters on the neurological outcome of out-of-hospital cardiac arrest: Results from the French National Cardiac Arrest Registry. Resuscitation. 2018. PMID: 30253228. doi:10.1016/j.resuscitation.2018.09.016
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。